AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy
Bowen Yan, David F. Claxton, Suming Huang, Yi Qiu
Topics & Concepts
Myeloid leukemiaCancer researchHaematopoiesisMutationStem cellBone marrowPopulationLeukemiaMedicineBiologyImmunologyOncologyInternal medicineGeneticsGeneEnvironmental healthAcute Myeloid Leukemia ResearchHistone Deacetylase Inhibitors ResearchMultiple Myeloma Research and Treatments